论文部分内容阅读
目的观察依达拉奉和降纤酶联合用于治疗急性脑梗死的临床效果。方法将80例急性脑梗死随机分成两组,40例进行依达拉奉联合降纤酶治疗,40例降纤酶和安慰剂治疗作为对照组,治疗前后采用卒中评分量表(ESS)进行评分,观察效果。结果依达拉奉联合降纤酶治疗效果高于降纤酶和安慰剂治疗,二者均无不良反应。结论依达拉奉联合降纤酶治疗急性脑梗死是安全有效的。
Objective To observe the clinical effect of edaravone and defibrase in the treatment of acute cerebral infarction. Methods Eighty patients with acute cerebral infarction were randomly divided into two groups, 40 patients were treated with edaravone combined with defibrase, 40 patients with defibrase and placebo were taken as control group, and were assessed by stroke rating scale (ESS) before and after treatment , Observe the effect. Results Edaravone combined defibrase treatment effect than defibrase and placebo treatment, both no adverse reactions. Conclusion Edaravone combined with defibrase in the treatment of acute cerebral infarction is safe and effective.